Advanced Pancreatic Adenocarcinoma
Oncology·MeSH: Pancreatic Neoplasms
5 drugs in development·3 companies·3 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| panitumumab | GH Research PLC (GHRS) |
Phase 2(2)
Phase 1(1)
| Drug | Company |
|---|---|
| anti-pd-1 | TriSalus Life Sciences Inc. (TLSI) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| sd-101 | TriSalus Life Sciences Inc. (TLSI) |
Compare drugs
Frequently asked questions
How many drugs are in development for Advanced Pancreatic Adenocarcinoma?
BioSniper tracks 5 drugs in development for Advanced Pancreatic Adenocarcinoma across 3 companies.
How many clinical trials target Advanced Pancreatic Adenocarcinoma?
There are 3 clinical trials targeting Advanced Pancreatic Adenocarcinoma tracked by BioSniper.
Deep-dive into Advanced Pancreatic Adenocarcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis